Results 51 to 60 of about 18,647 (241)
A life for autoimmune blistering diseases: in memoriam Detlef Zillikens
Frontiers in Immunology, 2023 Detlef Zillikens, MD, director and chair of the Department of Dermatology at the University of Lübeck, Lübeck, Germany, died in September 2022, aged only 64.
Jennifer E. Hundt +25 more
doaj +1 more source
Journal of Dental Education, EarlyView.ABSTRACT Objectives This study provides a descriptive, multi‐institutional comparison of dental students' recognition accuracy and management decisions of oral soft tissue pathological entities across four US dental schools. While prior single‐institution studies have evaluated diagnostic ability, this work provides a multi‐institutional comparison to ...
Nicole McKee +7 more
wiley +1 more source
Anais Brasileiros de Dermatologia, 2019 Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, drug-induced cases and improvement in the diagnosis of the nonbullous presentations of the disease. A dysregulated T cell immune response and synthesis of IgG
Denise Miyamoto +3 more
openaire +5 more sources
Epiphora: A Structured Diagnostic Approach for the Otolaryngologist
World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.ABSTRACT Introduction Epiphora, or excessive tearing, has historically been predominantly managed by ophthalmologists. However, as there is substantial overlap between ophthalmic and otolaryngologic anatomy and pathology that may contribute to epiphora, patients with this symptom often present to otolaryngologists as well.
Luke M. O'Neil +7 more
wiley +1 more source
Role of T cells in the pathogenesis of mucous membrane pemphigoid
, 2006 There are a number of autoimmune subepidermal blistering disorders in which the presence of autoantibodies has been well documented. These include pemphigoid gestationis, linear immunoglobulin A disease, bullous pemphigoid, lichen planus pemphigoides and
Ogg, Graham S. +2 more
core +1 more source
[Pemphigoid nodularis triggered by hypereosinophilic syndrome?] [PDF]
, 2006 Pemphigoid nodularis (PN) is a rare clinical variant of pemphigoid characterized by prurigo-like skin lesions and antibodies against BP180 and BP230 characteristic for bullous pemphigoid. Interestingly, most PN patients never develop blisters.
Simon, D +7 more
core +1 more source
Frontiers in Immunology, 2023 Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease (sAIBD). In addition to disease causing autoantibodies, several leukocyte subsets, including mast cells and eosinophils, play key roles in mediating skin inflammation.
Hiroshi Koga +5 more
doaj +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Although population‐based studies have reported an increased risk of bullous pemphigoid and pemphigus associated with dipeptidyl peptidase‐4 (DPP‐4) inhibitors, there is limited, well‐designed epidemiological evidence for pemphigus vulgaris (PV), which has only been supported by case reports thus far.
Jaein Lee, Jae Hyun Bae, Seokyung Hahn
wiley +1 more source
, 2014 Introduction. The correlation between psoriasis and metabolic syndrome has been well established. Psoriasis may also coexist with autoimmune blistering disease, mainly bullous pemphigoid.
Anna Leśniewska +4 more
core +1 more source
Janus kinase inhibitors in autoimmune bullous diseases
Frontiers in Immunology, 2023 Autoimmune bullous disease (AIBD) is a severe skin disorder caused by autoantibodies that target intercellular or cell-matrix adhesion proteins.
Dawei Huang +9 more
doaj +1 more source